A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
Recruiting now · Phase 4
Conditions studied: Schizophrenia, Schizoaffective Disorder, Bipolar Disorder, Major Depressive Disorder, Tardive Dyskinesia
In brief
This study will evaluate the efficacy of valbenazine on clinician- and patient-reported outcomes in participants with TD while receiving or after stopping a VMAT2 inhibitor.
Key facts
- Study ID
- NCT07105111
- Run by
- Neurocrine Biosciences
- People needed
- 50
- Starts
- 2025-08-29
- Expected to finish
- 2027-01-01
- Last updated by the study team
- 2026-06-16
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Neurocrine Clinical Site — Bryant, Arkansas, United States (enrolling)
- Neurocrine Clinical Site — Chino, California, United States (enrolling)
- Neurocrine Clinical Site — Fountain Valley, California, United States (enrolling)
- Neurocrine Clinical Site — Fresno, California, United States (enrolling)
- Neurocrine Clinical Site — Long Beach, California, United States (enrolling)
- Neurocrine Clinical Site — Orange, California, United States (enrolling)
- Neurocrine Clinical Site — Redlands, California, United States (enrolling)
- Neurocrine Clinical Site — San Diego, California, United States (enrolling)
- Neurocrine Clinical Site — Bonita Springs, Florida, United States (enrolling)
- Neurocrine Clinical Site — Hialeah, Florida, United States (enrolling)
- Neurocrine Clinical Site — Miami, Florida, United States (enrolling)
- Neurocrine Clinical Site — Miami, Florida, United States (enrolling)
- Neurocrine Clinical Site — Orange City, Florida, United States (enrolling)
- Neurocrine Clinical Site — Port Charlotte, Florida, United States (enrolling)
- Neurocrine Clinical Site — Tampa, Florida, United States (enrolling)
- Neurocrine Clinical Site — Augusta, Georgia, United States (enrolling)
- Neurocrine Clinical Site — Marietta, Georgia, United States (enrolling)
- Neurocrine Clinical Site — Naperville, Illinois, United States (enrolling)
- Neurocrine Clinical Site — Omaha, Nebraska, United States (enrolling)
- Neurocrine Clinical Site — Independence, Ohio, United States (enrolling)
- Neurocrine Clinical Site — Austin, Texas, United States (enrolling)
- Neurocrine Clinical Site — Richmond, Virginia, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.